Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
4.010
+0.050 (1.26%)
At close: Nov 13, 2026, 4:00 PM EST
3.994
-0.016 (-0.41%)
After-hours: Nov 13, 2026, 5:06 PM EST
Artiva Biotherapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Artiva Biotherapeutics stock has a consensus rating of "Buy" and an average price target of $20.75. The average 1-year stock price forecast is 417.46% higher than the current stock price, while the lowest is $4.00 (-0.25%) and the highest is $40 (+897.51%).
Price Target: $20.75 (+417.46%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Artiva Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Downgrades $23 → $4 | Hold | Downgrades | $23 → $4 | -0.25% | Oct 29, 2026 |
| Needham | Needham | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 27, 2026 |
| Wedbush | Wedbush | Hold Downgrades $4 | Hold | Downgrades | $4 | -0.25% | Oct 27, 2026 |
| TD Cowen | TD Cowen | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $35 | Buy | Maintains | $35 | +772.82% | Oct 1, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.64
from -3.43
EPS Next Year
-1.98
from -2.64
EPS and Forward PE are based on non-GAAP adjusted numbers.